Navitas Semiconductor Receives Analyst Upgrades from Craig-Hallum and Rosenblatt
Navitas Semiconductor received 'Buy' rating upgrades from Craig-Hallum and Rosenblatt, driven by strong AI infrastructure demand and recent quarterly performance.
Stocks · News reference
AMIX: 126% | Autonomix Medical shares are trading higher ahead of the Patent and Trademark Office's decision to grant the company U.S. Patent No. 12,714,780 titled "Systems and Methods for Regulating Organ
Reference Details
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
Keep reading
Navitas Semiconductor received 'Buy' rating upgrades from Craig-Hallum and Rosenblatt, driven by strong AI infrastructure demand and recent quarterly performance.
Needham maintained its Buy rating on Navitas Semiconductor while adjusting its price target to $15 from $21.
Rosenblatt Securities has upgraded its rating for Navitas Semiconductor (NVTS) from Neutral to Buy.
Navitas Semiconductor reported its third quarter 2026 financial results, highlighting 33% sequential revenue growth and providing guidance for the fourth quarter.
Navitas Semiconductor reported 38% Q3 revenue growth to $14.0 million, driven by high-power AI data center chips, with shares rising 5% after-hours. However, Q4 guidance shows operating costs jumping 50% due to the Claros acquisition, indicating losses will widen before narrowing. Cash more than doubled to $531.5 million, though the source remains unexplained.
Filed: 2026-11-03 AccNo: 0001437749-26-034696 Size: 308 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers Item 5.07: Submission of Matters to a Vote of Security Holders Item 9.01: Financial Statements and Exhibits